Issue: Volume IV No. 9 - June 23, 1997

Where Are “Laboratories Of The Future?”

At this year’s Executive War College in New Orleans last May 20-21, there was plenty of talk about the radical changes laboratories are undergoing. But one question went unanswered: If laboratories must change, what should they look like after they change? Our Editor, Robert Michel, criss-crosses the country looking for laboratory models which represent the …

Where Are “Laboratories Of The Future?” Read More »

Future Laboratory Model Found In Oklahoma City

CEO SUMMARY: Even as commercial laboratories struggle to maintain financial solvency, Urocor displays phenomenal growth in specimen volume, market share and revenue during the last five years. It is no accident that this laboratory is succeeding. Urocor’s executives use sophisticated management techniques, with remarkable results. PROBABLY THE MOST SPECTACULAR success story in the clinical laboratory …

Future Laboratory Model Found In Oklahoma City Read More »

Management Philosophy Drives UroCor’s Success

CEO SUMMARY: In the year 1997, UroCor shows a financial strength and growth potential unlike most commercial laboratories. UroCor’s current success is a direct result of how UroCor’s management did things differently during the years from 1991 to the present. Much of UroCor’s success can be attributed to doing simple things better than the competition. …

Management Philosophy Drives UroCor’s Success Read More »

Market Assessment Leads Quest To Do Several Deals

CEO SUMMARY: Quest CEO Ken Freeman is moving rapidly to restructure Quest’s regional laboratory system. Using the financial head-start provided by the January spin-off from Corning, Inc., Quest purchased one laboratory and seeks to do joint venture deals in several cities. Quest’s activities will change the competitive situation in cities affected by these developments. Competition …

Market Assessment Leads Quest To Do Several Deals Read More »

President Of SmithKline Lab Unit Respected As “Tough Competitor”

WITH troubles at Corning/Quest and LabCorp attracting publicity during the previous 18 months, few people observed a discreet but important change at SmithKline Beecham Clinical Laboratories (SBCL). John B. Okkerse, Jr., Ph.D. has quietly assumed full executive responsibility at the $1 billion company. Although Okkerse was promoted to President in 1995, Vickery Stoughton was the Chief …

President Of SmithKline Lab Unit Respected As “Tough Competitor” Read More »

Pap Smear Technologies Battle For Market Share

CEO SUMMARY: Cytyc, NeoPath and Neuromedical each tapped the public capital markets during the past 18 months. Now investors expect to see earnings growth and dividends as soon as possible. Clinical laboratories should expect intensified sales and marketing efforts from these three companies as they strive to increase sales. Probably the most ubiquitous sales representatives …

Pap Smear Technologies Battle For Market Share Read More »

Shareholders Hugely Oversubscribe LabCorp’s $500 Million Offering

COMMERCIAL LABORATORIES may be regaining favor on Wall Street. Laboratory Corporation of America’s $500 million convertible stock offering not only sold out, but was over-subscribed by a huge amount. In addition to the 10 million convertible shares offered, subscription agreements and payments for an additional 3.98 million shares were tendered. Investor response to LabCorp’s offering …

Shareholders Hugely Oversubscribe LabCorp’s $500 Million Offering Read More »

“June 23, 1997 Intelligence: Late Breaking Lab News”

Joint Venture Hospital Laboratory network (JVHL) of Detroit added a not her hospital system to its growing regional laboratory network. M-Labs, the laboratory division of the University of Michigan Health System, joined JVHL. This is the eighth hospital system laboratory division to be come an equity member of JVHL. ADD TO…JVHL Jack Shaw, Executive Director …

“June 23, 1997 Intelligence: Late Breaking Lab News” Read More »